The transformations now taking place in the emerging field of connected packaging have the potential to address all these product challenges—protection, engagement, traceability—while delivering powerful supply chain insight. Register now to learn more.
Why is diversity in clinical trials important? Minority populations are more likely to be diagnosed with certain cancers, stroke, diabetes, and are more likely to die prematurely than White Americans. Health disparities by race and ethnicity could increase if minority populations are not included in clinical trials.
Register now to learn who is participating in clinical trials and why.
Integrated Imaging and EDC ensures the right data is presented to the right users at the right time, free from manual intervention. Taking data reconciliation to a whole new level means your trial not only saves time, resources and cost, but also drastically reduces your clinical trial risk. Register now to learn more.
When consistent supply for your patients is critical, you can rely on an ANI Global Source collaboration. ANI Global Source is a specialty CDMO supporting late stage development and commercial pharmaceutical manufacture of:
- Oral dosage forms
- Creams & Gels
- Potent compounds
- Class II controlled substances
Manufacturing your product requires more than raw materials and established processes. At ANI Global Source, expertise, safety, reliability, and integrity are at the core of everything we produce. Visit us at booth 121H63 to learn more.
Fully integrated CDMO for biologics bulk drug substance and sterile injectable drug products. Benefit from our turnkey upstream and downstream support for eukaryotic, microbial and viral expression as well as finished dose services.
- Cell, Viral, and Microbial
- Single-Use Platform (2L to 4000L Scale)
- Process & Analytical Development
- Parenteral Formulation Development
- Fill/Finish Capabilities
- Vials & Pre-Filled Syringes
- Liquid & Lyophilized products
To learn more, visit us at CPhI WW, Stand 120A50 or contact us at [email protected]
In this webinar, we'll highlight some of these approaches and demonstrate how data and analytics can be used to gain a competitive advantage and create differentiation. Register now.
Formulation challenges. Clinical supply hurdles. Lifecycle management. Risk mitigation. Patent expiry concerns. At BioPharma Solutions, a business unit of Baxter, we know the high-stakes challenges you face in today’s complex parenteral marketplace — and how the work we do is vital to the patients you serve.
If you have an injectable molecule and are looking for sterile contract manufacturing services, we invite you to stop by our stand at CPhI Worldwide in Frankfurt (Hall 12.1, Space F81) to meet with a representative and discuss how we can help you achieve your molecule’s full potential. Learn more.
We assists clients with small molecule cGMP projects from lab to multi-metric ton quantities. Our team provides phase appropriate route and process development solutions for short-term scale-up and long-term manufacturing challenges.
With vast experience in downstream purification techniques (chromatography, crystallization), we have completed 100+ chemical API projects (10 ongoing commercial products), including: complex multi-step synthesis, potent handling, and controlled substances. FDA & Health Canada inspected.
To meet our team at CPhI (booth 121H42), email [email protected]!
Discover an approach to solubility and bioavailability enhancement of poorly water soluble drug molecules, approaches to aqueous-based spray drying of bio-pharmaceuticals as well as small molecules intended for inhalation delivery. Join us for this webinar to learn more.
Register for this webinar to learn about the tools and technologies for creating dosage forms such as orally disintegrating tablets (ODTs), multi-particulates, and modified release formulations.
In this interview, Greg Fry, Patient and Consumer Analytics - ZS Associates, discusses consumer data and marketing trends and how to optimize digital campaigns. Watch the video.
In this webinar, you will hear from Alan Louie, Ph.D, Research Director at IDC, Bill Swavely, CIO at Pharm-Olam, and Rama Kondru, Ph.D, CIO at Medidata about the need for a platform approach in clinical research, the rationale for switching from disparate systems to a unified platform, and the benefits that could be realized. Register now.
This webinar will address how the use of technology for deploying data and analytic standards can be utilized to meet the challenge of understanding and comparing findings between studies conducted by different researchers, by facilitating the standardization, transparency, reproducibility, and replicability of RWD research. Register now.
In this webinar, we'll share insights to harness the strategic value of real world data to build optimized drug development programs that minimize the time and cost of sponsor-driven studies. Register now!
Join us for this webinar as we bring together a panel of industry experts to discuss the changing landscape of biosimilar development and how it will affect pricing in the future.
With increasing competition for patients, the ability to effectively and efficiently execute on clinical development plans has increased focus on alternative data sources. In this one-hour session attendees will hear from former FDA leaders and industry experts who will address what Synthetic Control is and how it can be leveraged in clinical development.
Eight years after the FDA issued its guidance of process validation, some still ask the question “Is process characterization optional anymore?” This webinar will cover the basics of process characterization, whether it is optional or not, and what “good” process characterization really looks like. Register now!
As companies face pressure to bring drugs to market quicker & at minimal cost, pharma & biotech companies are outsourcing parts of drug development & manufacturing process. Outsourcing eliminates the need to maintain expensive in-house facilities & provides access to other technologies & expertise. Click here to download the whitepaper today!
In this industry, even small improvements to streamline R&D processes can lead to substantially higher revenue and lower costs. To achieve those goals, pharmaceutical companies need to leverage their massive data assets that include decades of research and clinical trial data. Download this whitepaper to learn more.
Developing a combination product? Join experts Susan Neadle, Sr. Director, Global Value Chain Quality Design, Johnson & Johnson and Jennifer Riter, Sr. Director, Lab Services, West to learn how you can create an effective risk management program. Register Now!
Hear from Moderna’s Chief Digital and Operational Excellence Officer how they have eliminated data siloes to accelerate data-driven decisions at an enterprise level, and established a production environment capable of consistent delivery of complex drug products including a “batch of one”. Register Now!
Patient influencers on social platforms like Facebook, Instagram and Twitter are driving high-value actions for brands, and pharma is no exception. Download our report to discover how influencers will help you boost brand trust and best practices for working with influencers.
This presentation will discuss how predictable stability and solubility can minimize development timelines and cost. Attend to hear about two case studies exemplifying the importance of understanding the hydration space of an API and how hydrate formation may be avoided by development of a robust crystallization procedure.
Please join the experts from CMIC Group, Japan’s largest CRO with over 30 years of analytical service experiences in US and Japan, to learn the insights and tips on developing an immunogenicity assay in a regulated laboratory, selecting a format for the neutralization assay for immunogenicity assessments, and quantitative Bioanalysis of Oligonucleotides by LC-MS. Register Now!
In this webinar, manufacturing experts will discuss the benefits of end-to-end solutions and share case studies on how flexible manufacturing strategies can accommodate the changing landscape of pharmaceutical products and help bring a drug to market. Register now!
Download this whitepaper to learn how developing a digitized, integrated lab environment can facilitate collaborations and take advantage of technological advancements like machine learning to streamline and automate workflows- making research more productive.
Enrollment can be very fast for post-operative acute pain studies which brings with it unique challenges in study execution. This webinar will address the differences between bunionectomy and abdominoplasty models, the importance of rater and site training, and considerations for data collection and analysis.
This survey seeks to gain insight on trial sponsors’ perspective on offering a DTP option and their current level of awareness and understanding of any factors that may influence their ability to do so. Please take 5 minutes to share your thoughts. The first 50 qualified respondents will receive a $5 Amazon gift certificate.
Join Lash Group’s Vice President of Market Development and Strategy, Michael Craig, and Product Director of Adherence Services, Dale Hanna, as they discuss the critical nature of clinical expertise in tech-enabled patient support solutions and the importance of training teams in empathy. Register now.
For years, a debate has waged on about the distinction between an organization’s general counsel (GC) and chief ethics and compliance officer (CECO). Download this whitepaper to learn more about the role of a CECO in Life Sciences and the 10 ingredients for independence.
The Brand Recognition Survey aims to understand current trends and address your needs. The first 50 qualified participants will be rewarded with a $10 Amazon gift card for your time and feedback. Please take 5 minutes to share your thoughts and enter for your chance to win.
This research aims to understand the importance of product innovation and dose forms in driving new product design and development, consumer engagement and purchase interest for Over-the-Counter medicines. The first 50 qualified respondents will receive a $5 Amazon gift card, and all qualified respondents will be entered to win a $50 Amazon gift card. Take the survey now.
Nick Dyer ( CEO, Catalyst Clinical Research ) and Stacey Yount ( VP of Product, Trial Management Solutions, Medidata ) will discuss the industry challenges and share how Medidata’s Rave CTMS breaks down operational silos by providing a centralised solution to manage issues, deviations and associated actions. Register now.
This survey examines the main factors that motivate innovators to consider advanced dosage forms (ie: modified release, multiarticulate, ODT, etc) for the new molecules in their development pipelines, as well as how they select the most suitable technologies to create those dosage forms. The first 50 qualified respondents will receive a $5 Amazon gift card, and all qualified respondents will be entered to win a $50 Amazon gift card. Take the survey now!
Join this webinar to hear from two of Veeva’s subject matter experts, Lalana Dararutana and Serena Peirson, on ways to achieve a successful RIM implementation. Register Now!
Join this webinar to learn how Raman, NIR, and mass spectrometry provide raw material ID and bioprocess monitoring for:
- cell culture and fermentation monitoring
- moisture analysis of lyophilized materials
- near real-time discrimination of bulk protein product
Join this webinar to learn how industry leaders are using DocuSign to modernize their systems of agreement while implementing GxP validation processes. Hear best practices about how to simplify and scale your business processes while also reducing your regulatory risk.
This Fierce webinar will feature clinical trial site leaders and R&D executives, who will pass along the latest strategies for boosting site and patient enrollment in phase 1 trials. They will discuss best practices for communicating with both investigators and patients. Register now to learn more.
You’ve identified your product as a candidate for approval via the 505(b)(2) pathway and completed a successful pre-IND meeting. What comes next? Register now to find out!
In this whitepaper, UBC will show the value of standardizing diverse registry data into a common structure to assemble real-world evidence to complement ad hoc observational research. Download Now!
Understanding the existing relationships among health care professionals not only optimizes your ability to connect with them, but it also maximizes the impact of marketing communications in achieving the desired clinical behavior change that will improve patient care.
Join our webinar to learn more about how you can do more with less through “HCP Impact” strategies.
It is increasingly important for pharmaceutical brand teams to provide information about available patient savings that can help providers have full transparency into the drug prices their eligible patients are likely to pay. This infographic aims to help inform brand teams as they make critical decisions about meeting the demand for price transparency. Download Now!
Register for this webinar to get insights from industry experts on:
- Demand led manufacturing and supply
- Forecasting and inventory management
- Innovations and considerations in labeling
- Direct-to-patient distribution
In this publication, Blue Latitude Health maps the journey of stakeholders impacted by the rise of precision medicine today.
Download the report for:
- Exclusive interviews with major players from patients to oncologists, healthcare systems and industry
- Industry gamechangers reveal how they are innovating in precision medicine
- Insights on the unmet needs of seven core stakeholders, as well as information on how to turn these challenges into engagement opportunities.
Increasingly complex clinical trials place a tremendous burden on study sites, exacerbating already-troubling recruitment and enrollment issues. Overwhelmed, many sites may not be up to the task or have the appropriate infrastructure, creating costly delays that keep new therapies from patients. However, strategically placed on-the-ground resources can ease that burden, streamlining enrollment, making sites more agile and offering patients personalized attention that leads to conversion and retention. Download the whitepaper to learn more.
Join us to learn how recent enhancements to protein expression platforms can significantly increase expression levels for complex proteins. New technologies for simplifying and increasing expression levels of multi-chain and complex proteins will be presented. Register Now!
Join this webinar to learn the five characteristics of a unified platform and how each benefits clinical research both for a single trial and across your suite of research efforts. Register Now!
Modernizing the way studies are conducted can continue to evolve with the use of more accessible information. Mobile specimen collections and health data support this evolution and broaden the scope for which types of studies can be conducted virtually. Download this whitepaper to learn more.
Low patient numbers & high unmet need for rare disease treatments require manufacturers to develop an evidence package that meets all stakeholders' needs to achieve EU access. Integrated regulatory & HTA scientific advice and multi-country collaborations can help evidence planning to increase access. Download the whitepaper.